Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134988) titled 'Clinical Outcomes of Recombinant Fibroblast Growth Factor Therapy in Patients with Diabetic Foot Ulcers After Discharge' on Oct. 22.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University
Condition:
Diabetic foot ulcer
Intervention:
FGF combined treatment group:None
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-11-01
Target Sample Size: FGF combined treatment group:250;Standard care group:250;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=...